[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Marine Pharmaceuticals Industry Research Report 2024

February 2024 | 106 pages | ID: M2F9ED31C0E6EN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report aims to provide a comprehensive presentation of the global market for Marine Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marine Pharmaceuticals.

The Marine Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Marine Pharmaceuticals market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Marine Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Seattle Genetics
  • DSM
  • Eisai Co
  • Takeda
  • BASF
  • Amway
  • Pfizer
  • Pelagia (EPAX)
  • Pharma Mar SA
  • Croda
  • GNC
  • GSK
  • TerSera Therapeutics
  • Nordic Naturals
  • Carlson Labs
Product Type Insights

Global markets are presented by Marine Pharmaceuticals type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Marine Pharmaceuticals are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).

Marine Pharmaceuticals segment by Type
  • Drugs
  • Health Supplement
Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).

This report also outlines the market trends of each segment and consumer behaviors impacting the Marine Pharmaceuticals market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Marine Pharmaceuticals market.

Marine Pharmaceuticals segment by Application
  • Hospital & Clinic
  • Pharmacy
  • Other
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Marine Pharmaceuticals market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Marine Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Marine Pharmaceuticals industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Pharmaceuticals.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Marine Pharmaceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Marine Pharmaceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Marine Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Global Market Growth Prospects
  2.2.1 Global Marine Pharmaceuticals Market Size (2019-2030) & (US$ Million)
  2.2.2 Global Marine Pharmaceuticals Sales (2019-2030)
  2.2.3 Global Marine Pharmaceuticals Market Average Price (2019-2030)
2.3 Marine Pharmaceuticals by Type
  2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
  1.2.2 Drugs
  1.2.3 Health Supplement
2.4 Marine Pharmaceuticals by Application
  2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
  2.4.2 Hospital & Clinic
  2.4.3 Pharmacy
  2.4.4 Other

3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS

3.1 Global Marine Pharmaceuticals Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Marine Pharmaceuticals Sales (M Units) of Manufacturers (2019-2024)
3.3 Global Marine Pharmaceuticals Revenue of Manufacturers (2019-2024)
3.4 Global Marine Pharmaceuticals Average Price by Manufacturers (2019-2024)
3.5 Global Marine Pharmaceuticals Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Marine Pharmaceuticals, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Marine Pharmaceuticals, Product Type & Application
3.8 Global Manufacturers of Marine Pharmaceuticals, Date of Enter into This Industry
3.9 Global Marine Pharmaceuticals Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition

4 MANUFACTURERS PROFILED

4.1 Seattle Genetics
  4.1.1 Seattle Genetics Company Information
  4.1.2 Seattle Genetics Business Overview
  4.1.3 Seattle Genetics Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.1.4 Seattle Genetics Marine Pharmaceuticals Product Portfolio
  4.1.5 Seattle Genetics Recent Developments
4.2 DSM
  4.2.1 DSM Company Information
  4.2.2 DSM Business Overview
  4.2.3 DSM Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.2.4 DSM Marine Pharmaceuticals Product Portfolio
  4.2.5 DSM Recent Developments
4.3 Eisai Co
  4.3.1 Eisai Co Company Information
  4.3.2 Eisai Co Business Overview
  4.3.3 Eisai Co Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.3.4 Eisai Co Marine Pharmaceuticals Product Portfolio
  4.3.5 Eisai Co Recent Developments
4.4 Takeda
  4.4.1 Takeda Company Information
  4.4.2 Takeda Business Overview
  4.4.3 Takeda Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.4.4 Takeda Marine Pharmaceuticals Product Portfolio
  4.4.5 Takeda Recent Developments
4.5 BASF
  4.5.1 BASF Company Information
  4.5.2 BASF Business Overview
  4.5.3 BASF Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.5.4 BASF Marine Pharmaceuticals Product Portfolio
  4.5.5 BASF Recent Developments
4.6 Amway
  4.6.1 Amway Company Information
  4.6.2 Amway Business Overview
  4.6.3 Amway Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.6.4 Amway Marine Pharmaceuticals Product Portfolio
  4.6.5 Amway Recent Developments
4.7 Pfizer
  4.7.1 Pfizer Company Information
  4.7.2 Pfizer Business Overview
  4.7.3 Pfizer Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.7.4 Pfizer Marine Pharmaceuticals Product Portfolio
  4.7.5 Pfizer Recent Developments
4.8 Pelagia (EPAX)
  4.8.1 Pelagia (EPAX) Company Information
  4.8.2 Pelagia (EPAX) Business Overview
  4.8.3 Pelagia (EPAX) Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.8.4 Pelagia (EPAX) Marine Pharmaceuticals Product Portfolio
  4.8.5 Pelagia (EPAX) Recent Developments
4.9 Pharma Mar SA
  4.9.1 Pharma Mar SA Company Information
  4.9.2 Pharma Mar SA Business Overview
  4.9.3 Pharma Mar SA Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.9.4 Pharma Mar SA Marine Pharmaceuticals Product Portfolio
  4.9.5 Pharma Mar SA Recent Developments
4.10 Croda
  4.10.1 Croda Company Information
  4.10.2 Croda Business Overview
  4.10.3 Croda Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  4.10.4 Croda Marine Pharmaceuticals Product Portfolio
  4.10.5 Croda Recent Developments
6.11 GNC
  6.11.1 GNC Company Information
  6.11.2 GNC Marine Pharmaceuticals Business Overview
  6.11.3 GNC Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  6.11.4 GNC Marine Pharmaceuticals Product Portfolio
  6.11.5 GNC Recent Developments
6.12 GSK
  6.12.1 GSK Company Information
  6.12.2 GSK Marine Pharmaceuticals Business Overview
  6.12.3 GSK Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  6.12.4 GSK Marine Pharmaceuticals Product Portfolio
  6.12.5 GSK Recent Developments
6.13 TerSera Therapeutics
  6.13.1 TerSera Therapeutics Company Information
  6.13.2 TerSera Therapeutics Marine Pharmaceuticals Business Overview
  6.13.3 TerSera Therapeutics Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  6.13.4 TerSera Therapeutics Marine Pharmaceuticals Product Portfolio
  6.13.5 TerSera Therapeutics Recent Developments
6.14 Nordic Naturals
  6.14.1 Nordic Naturals Company Information
  6.14.2 Nordic Naturals Marine Pharmaceuticals Business Overview
  6.14.3 Nordic Naturals Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  6.14.4 Nordic Naturals Marine Pharmaceuticals Product Portfolio
  6.14.5 Nordic Naturals Recent Developments
6.15 Carlson Labs
  6.15.1 Carlson Labs Company Information
  6.15.2 Carlson Labs Marine Pharmaceuticals Business Overview
  6.15.3 Carlson Labs Marine Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
  6.15.4 Carlson Labs Marine Pharmaceuticals Product Portfolio
  6.15.5 Carlson Labs Recent Developments

5 GLOBAL MARINE PHARMACEUTICALS MARKET SCENARIO BY REGION

5.1 Global Marine Pharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Marine Pharmaceuticals Sales by Region: 2019-2030
  5.2.1 Global Marine Pharmaceuticals Sales by Region: 2019-2024
  5.2.2 Global Marine Pharmaceuticals Sales by Region: 2025-2030
5.3 Global Marine Pharmaceuticals Revenue by Region: 2019-2030
  5.3.1 Global Marine Pharmaceuticals Revenue by Region: 2019-2024
  5.3.2 Global Marine Pharmaceuticals Revenue by Region: 2025-2030
5.4 North America Marine Pharmaceuticals Market Facts & Figures by Country
  5.4.1 North America Marine Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
  5.4.2 North America Marine Pharmaceuticals Sales by Country (2019-2030)
  5.4.3 North America Marine Pharmaceuticals Revenue by Country (2019-2030)
  5.4.4 U.S.
  5.4.5 Canada
5.5 Europe Marine Pharmaceuticals Market Facts & Figures by Country
  5.5.1 Europe Marine Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
  5.5.2 Europe Marine Pharmaceuticals Sales by Country (2019-2030)
  5.5.3 Europe Marine Pharmaceuticals Revenue by Country (2019-2030)
  5.5.4 Germany
  5.5.5 France
  5.5.6 U.K.
  5.5.7 Italy
  5.5.8 Russia
5.6 Asia Pacific Marine Pharmaceuticals Market Facts & Figures by Country
  5.6.1 Asia Pacific Marine Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
  5.6.2 Asia Pacific Marine Pharmaceuticals Sales by Country (2019-2030)
  5.6.3 Asia Pacific Marine Pharmaceuticals Revenue by Country (2019-2030)
  5.6.4 China
  5.6.5 Japan
  5.6.6 South Korea
  5.6.7 India
  5.6.8 Australia
  5.6.9 China Taiwan
  5.6.10 Indonesia
  5.6.11 Thailand
  5.6.12 Malaysia
5.7 Latin America Marine Pharmaceuticals Market Facts & Figures by Country
  5.7.1 Latin America Marine Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
  5.7.2 Latin America Marine Pharmaceuticals Sales by Country (2019-2030)
  5.7.3 Latin America Marine Pharmaceuticals Revenue by Country (2019-2030)
  5.7.4 Mexico
  5.7.5 Brazil
  5.7.6 Argentina
5.8 Middle East and Africa Marine Pharmaceuticals Market Facts & Figures by Country
  5.8.1 Middle East and Africa Marine Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
  5.8.2 Middle East and Africa Marine Pharmaceuticals Sales by Country (2019-2030)
  5.8.3 Middle East and Africa Marine Pharmaceuticals Revenue by Country (2019-2030)
  5.8.4 Turkey
  5.8.5 Saudi Arabia
  5.8.6 UAE

6 SEGMENT BY TYPE

6.1 Global Marine Pharmaceuticals Sales by Type (2019-2030)
  6.1.1 Global Marine Pharmaceuticals Sales by Type (2019-2030) & (M Units)
  6.1.2 Global Marine Pharmaceuticals Sales Market Share by Type (2019-2030)
6.2 Global Marine Pharmaceuticals Revenue by Type (2019-2030)
  6.2.1 Global Marine Pharmaceuticals Sales by Type (2019-2030) & (US$ Million)
  6.2.2 Global Marine Pharmaceuticals Revenue Market Share by Type (2019-2030)
6.3 Global Marine Pharmaceuticals Price by Type (2019-2030)

7 SEGMENT BY APPLICATION

7.1 Global Marine Pharmaceuticals Sales by Application (2019-2030)
  7.1.1 Global Marine Pharmaceuticals Sales by Application (2019-2030) & (M Units)
  7.1.2 Global Marine Pharmaceuticals Sales Market Share by Application (2019-2030)
7.2 Global Marine Pharmaceuticals Revenue by Application (2019-2030)
  6.2.1 Global Marine Pharmaceuticals Sales by Application (2019-2030) & (US$ Million)
  6.2.2 Global Marine Pharmaceuticals Revenue Market Share by Application (2019-2030)
7.3 Global Marine Pharmaceuticals Price by Application (2019-2030)

8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET

8.1 Marine Pharmaceuticals Value Chain Analysis
  8.1.1 Marine Pharmaceuticals Key Raw Materials
  8.1.2 Raw Materials Key Suppliers
  8.1.3 Marine Pharmaceuticals Production Mode & Process
8.2 Marine Pharmaceuticals Sales Channels Analysis
  8.2.1 Direct Comparison with Distribution Share
  8.2.2 Marine Pharmaceuticals Distributors
  8.2.3 Marine Pharmaceuticals Customers

9 GLOBAL MARINE PHARMACEUTICALS ANALYZING MARKET DYNAMICS

9.1 Marine Pharmaceuticals Industry Trends
9.2 Marine Pharmaceuticals Industry Drivers
9.3 Marine Pharmaceuticals Industry Opportunities and Challenges
9.4 Marine Pharmaceuticals Industry Restraints

10 REPORT CONCLUSION

11 DISCLAIMER



More Publications